Increased serum levels of soluble CD30 in patients with common variable immunodeficiency and its clinical implications

J Clin Immunol. 2008 Jan;28(1):78-84. doi: 10.1007/s10875-007-9135-6. Epub 2007 Oct 3.

Abstract

Common variable immunodeficiency (CVID) is a heterogeneous group of disorders, characterized by hypogammaglobulinemia and increased susceptibility to recurrent pyogenic infections, autoimmunity, and malignancies. Twenty-five cases with CVID (18 male and 7 female) and 25 healthy volunteers were investigate in this study. Soluble CD30 (sCD30) serum levels of the subjects were measured and compared. Serum levels of sCD30 in the patients with CVID were significantly increased in comparison with controls (36.93 +/- 32.38 vs 5.27 +/- 1.32 U/ml, P < 0.001). The group of patients with splenomegaly and reversed ratio of CD3+CD4+ T cells/CD3+CD8+ T cells had the highest serum levels of sCD30 (66.01 +/- 43.34 U/ml) in comparison with other patients (P = 0.010). High levels of sCD30 in the CVID patients with splenomegaly and the presence of lymphoma in a patient with the highest level of sCD30 may suggest a soluble form of this marker as a prognostic tool in such diseases.

MeSH terms

  • Adolescent
  • Adult
  • B-Lymphocyte Subsets
  • Child
  • Child, Preschool
  • Common Variable Immunodeficiency / blood
  • Common Variable Immunodeficiency / immunology*
  • Female
  • Humans
  • Immunoglobulins / blood
  • Ki-1 Antigen / blood*
  • Lymphocyte Count
  • Male
  • Middle Aged
  • T-Lymphocyte Subsets

Substances

  • Immunoglobulins
  • Ki-1 Antigen